Answers are grounded in this paper and cite their sources.
Shows Nodal signaling induces vasculogenic mimicry in breast cancer models through Smad2/3, suggesting a therapeutic target.
// Wenchen Gong 1, * , Baocun Sun 1, 2, 3, * , Xiulan Zhao 1, 2 , Danfang Zhang 1, 2 , Junying Sun 1 , Tieju Liu 1, 2 , Qiang Gu 1, 2 , Xueyi Dong 1 , Fang Liu 1 , Yong Wang 1 , Xian Lin 1 , Yanlei Li 1 1 Department of Pathology, Tianjin Medical University, Tianjin, 300070, China 2 Department of Pathology, Tianjin General Hospital, Tianjin Medical University, Tianjin, 300052, China 3 Department of Pathology, Tianjin Cancer Hospital, Tianjin Medical University, Tianjin, 300060, China * These authors contributed equally to this work Correspondence to: Baocun Sun, email: baocunsun@aliyun.com Keywords: Nodal signaling, Smad2/3 pathway, VM, EMT, breast cancer Received: April 18, 2016 Accepted: September 14, 2016 Published: September 21, 2016 ABSTRACT Vasculogenic mimicry (VM) is a nonangiogenesis-dependent pathway that promotes tumor growth and disease progression. Nodal signaling has several vital roles in both embryo development and cancer progression. However, the effects of Nodal signaling on VM formation in breast cancer and its underlying mechanisms are ill-defined. We analyzed the relationship between Nodal signaling and VM formation in one hundred human breast cancer cases and the results showed that the expression of Nodal was significantly correlated with VM formation, tumor metastasis, differentiation grade, TNM stage and poor prognosis. Furthermore, up-regulation of Nodal expression promoted VM formation of breast cancer cells in vitro and in vivo . Knockdown of Nodal expression restrained VM formation. In addition, Nodal induced EMT and up-regulated the expression of Slug, Snail and c-Myc. We found that blocking the Smad2/3 pathway by administering SB431542 inhibited VM formation in breast cancer cell lines and xenografts. Taken together, Nodal signaling through the Smad2/3 pathway up-regulated Slug, Snail and c-Myc to induce EMT, thereby promoting VM formation. Our study suggests that the Nodal signaling pathway may serve as a therapeutic target to inhibit VM formation and improve prognosis in breast cancer patients.
No takes yet. Share an insight, caveat, or question.
Gong et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: